fda declaratory order semaglutide shortage resolved US judge upholds FDA's removal of Ozempic, Wegovy from drug list GLP-1 Saga Continues: FDA Ends

This observation has triggered a closer look at breath testing and what has changed physiologically, so clinicians can accurately interpret test findings

Retatrutide Side Effects: What to Expect 9

GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists: strengthened warnings on acute pancreatitis, including necrotising and fatal cases

Canadian regulated pharmacies maintain Novo Nordisk quality standards and require valid prescriptions

continues to offer a level of data protection that is essentially equivalent to the EU standards

Evidence: GLP-1 Medications and Cholesterol Semaglutide and Tirzepatide Earlier GLP-1s like semaglutide and dual agonists like tirzepatide already showed modest improvements in lipid profiles: LDL cholesterol reduction by 510% Triglyceride reduction by 1520% Mild HDL increase These effects were partly due to weight loss , but researchers suspected other mechanisms were at play